NAN.AX
NAN.AX
AU000000NAN9
NANOSONICS FPO [NAN]
Loading chart...

Company Profile

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Related stocks

7979.T
7979.T • Japan
SHOFU INC
2,284 JPY
513.67M USD 1Y +17.6%
7780.T
7780.T • Japan
MENICON CO LTD
1,871 JPY
877.96M USD 1Y +63%
605369.SS
605369.SS • China
ZHEJIANG GONGDONG MEDICAL TECHN
17.66 CNY
580.84M USD 1Y -7.1%
3360.T
3360.T • Japan
SHIP HEALTH CARE HOLDINGS INC
2,458.5 JPY
1.4B USD 1Y +5.9%
AGARWALEYE.NS
AGARWALEYE.NS • India
DR AGARWALS HEALTH CARE L
477.75 INR
1.56B USD 1Y -5.1%
6491.TW
6491.TW • Taiwan
PEGAVISION CORPORATION
403 TWD
970.43M USD 1Y +29.8%
AP4.SI
AP4.SI • Singapore
Riverstone
0.76 SGD
879.76M USD 1Y -5.6%
6699.HK
6699.HK • China
ANGELALIGN
82.3 HKD
1.8B USD 1Y +30.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
47.9% p.a.
Max Drawdown (5Y)
-59.6%
Sharpe Ratio (5Y)
-0.32
Beta Factor
1.15
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 47.3 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (47.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.1% in the extended horizon.
ende